<DOC>
	<DOCNO>NCT02098889</DOCNO>
	<brief_summary>Although Hyoscine N butyl bromide ( HBB ) use liberally facilitate cervical dilatation , little inconclusive data efficacy . The aim study determine efficacy safety HBB augmentation labor.420 total 1640 pregnant woman admit investigator clinic ( Sisli Ethal Training Research Hospital , Obstetrics Gynecology Department Obstetrics Service ) 37-41 gestational week , active phase ( cervical dilatation : 4 cm , cervical effacement : % 50 ) spontaneous labor vertex presentation enrol study . 382 include study . Patients randomize receive intravenously ( IV ) either 20 mg/ml HBB similar amount placebo ( 1 ml 0.9 % NaCl ) begin active phase labor . The medication apply single dose . The time elapsed second stage labor , second stage third stage measure .</brief_summary>
	<brief_title>Safety Study Hyoscine N Butyl Bromide Active Management Labor</brief_title>
	<detailed_description>The investigator aim study effect safety 20mg intravenous HBB shorten labor prima- multigravid women.The study design double blind , randomize , control trial compare two group intervention ; Intravenous 20 mg ( 1mL ) Hyoscine-N-Butylbromide ( HBB ) versus placebo ( 1mL saline ) primigravid multigravid women.Singleton , vertex presentation term ( gestational age range ; 37-41weeks ) primigravid multigravid woman without chronic pregnancy-induced disease include study . The investigator exclude case premature rupture membrane , preeclampsia , eclampsia , placental abruption , placenta previa , abnormal placental attachment , twin pregnancy , non- cephalic presentation , previous uterine surgery cephalopelvic disproportion.Randomization do use card .The woman allocate two group use seal enveloped system.A yellow red card place separately seal envelope . The syrinx contain drug placebo prepare investigational pharmacy staff label yellow red sticker . Each syringe contain either 1ml ( 20mg ) Hyoscine-N-Butylbromide ( HBB ) ( MOLIT ampule , Adeko , Turkey ) 1 ml normal saline solution ( placebo ) liquids colorless . The participant , nurse doctor blind syrinx . The patient ask pick one envelope order color card correspond sticker 's color syringe.Nurses apply select color label syringe patient . Participants receive content syringe single dose , give intravenously ( IV ) . A partogram drawn vaginal examination record every 2 hours.The active phase labor define 4 cm cervical dilatation 50 % cervical effacement presence regular uterine contraction ( 2-3 contraction every 10 minute ) . The drug give active phase achieve . Iatrogenic amniotomy perform woman spontaneous rupture membrane time cervical ripen 8 cm . The duration labor first , second third stage , oxytocin induction , iatrogenic amniotomy , pre- postpartum haemoglobin level , birth weight APGAR score record . Neonatal APGAR score determine 1 5 minute birth .</detailed_description>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>Singleton , vertex presentation term ( gestational age range ; 3741weeks ) primigravid multigravid woman without chronic pregnancyinduced diseases The case premature rupture membrane , preeclampsia , eclampsia , placental abruption , placenta previa , abnormal placental attachment , twin pregnancy , non cephalic presentation , previous uterine surgery cephalopelvic disproportion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cervix , active phase labor , Hyoscine-N-Butylbromide ( HBB )</keyword>
</DOC>